Adult-onset nephrotic syndrome following coronavirus disease vaccination | Zendy

Vivek Biradar | Zendy; Abhijit Konnur | Zendy; Sishir Gang | Zendy; Umapati Hegde | Zendy; Mohan Rajapurkar | Zendy; Hardik Patel | Zendy; Sachida Nand Pandey | Zendy; Shailesh Soni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adult-onset nephrotic syndrome following coronavirus disease vaccination

Author(s) -

Vivek Biradar,

Abhijit Konnur,

Sishir Gang,

Umapati Hegde,

Mohan Rajapurkar,

Hardik Patel,

Sachida Nand Pandey,

Shailesh Soni

Publication year - 2021

Publication title -

clinical kidney journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.033

H-Index - 40

eISSN - 2048-8513

pISSN - 2048-8505

DOI - 10.1093/ckj/sfab153

Subject(s) - medicine , prednisolone , nephrotic syndrome , vaccination , minimal change disease , covid-19 , pediatrics , disease , gastroenterology , glomerulonephritis , immunology , kidney , infectious disease (medical specialty) , focal segmental glomerulosclerosis

A 22-year-old healthy man was admitted for oedema 15 days after the first injection of the COVISHIELD coronavirus disease 2019 (COVID-19) vaccine (Oxford AstraZeneca) vaccine. Nephrotic syndrome was diagnosed and a kidney biopsy showed minimal change disease. Oral prednisolone was started at 1 mg/kg/day resulting in complete remission within 1 week.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research